SBS Genetech was founded as one of China’s earliest contract research organizations (CROs), specializing in custom synthesis of primers and probes. This laid the groundwork for delivering reliable molecular tools to domestic scientists at a time when research infrastructure was still emerging.

Expanded into custom gene synthesis, enabling researchers to build novel DNA constructs rapidly and cost-effectively. This capability accelerated genetic engineering, cloning, and basic genomics research.

Introduced high-quality peptide synthesis services, backed by robust HPLC and mass spectrometry validation. This empowered life science researchers with greater access to tailor-made peptides for immunology, drug development, and structural biology.

Released essential reagents for polymerase chain reaction, including high-fidelity DNA polymerases, thermostable reverse transcriptases, and ultrapure dNTPs. These foundations became the backbone of SBS Genetech’s enzymatic reagent portfolio.

Began international distribution, establishing SBS Genetech as a global reagent supplier. The brand quickly earned trust for its commitment to performance, consistency, and customer service.

Developed ready-to-use mastermixes for PCR, RT-PCR, and qPCR, significantly improving assay reproducibility and simplifying experimental workflows for research and diagnostics.

Designed integrated PCR reagent kits, combining matched primers, fluorescent probes, and internal controls. These offerings streamlined assay setup and reduced experimental variability.

Launched a comprehensive supply of over 100 phosphoramidite types for DNA synthesis, enabling researchers and synthesis companies to optimize oligo purity and modification flexibility.

Expanded enzyme portfolio to include more than 500 enzymes for DNA/RNA manipulation, cloning, sequencing, and diagnostic development. Each product was validated for activity and purity.

Introduced 100+ biochemical reagents, including buffers, stabilizers, substrates, and protein modification compounds, enriching SBS Genetech’s solutions for molecular biology and biochemistry labs.

SBS Genetech products were actively used in over 40 countries, with an international client base spanning universities, hospitals, biotech startups, and pharmaceutical companies.

Developed and released ultra-high fidelity DNA polymerases with up to 300× Taq fidelity, pushing the limits of accuracy in DNA amplification—especially in next-generation sequencing and precision cloning.

SBS Genetech’s reagents and enzymes were cited in more than 1,000 peer-reviewed scientific papers, underscoring their role in advancing both basic research and applied life sciences globally.

Pioneered cold-chain–free enzyme logistics through innovative freeze-dried formulations, ensuring reagent stability during global shipping and supporting field diagnostics and mobile laboratories.

Released thermostable reverse transcriptases with tolerance up to 72 °C, enabling more reliable reverse transcription in the presence of strong RNA secondary structures or inhibitors.

Introduced magnetic bead–based nucleic acid purification kits, delivering higher yield, cleaner prep, and compatibility with automated platforms—ideal for PCR, qPCR, and sequencing workflows.

Rapid expansion saw SBS Genetech supporting clients in over 60 countries, offering tailored reagent solutions and localized technical support to meet diverse research demands.

Launched DNA-Free enzymes that eliminate host DNA contamination, allowing for ultra-sensitive detection in diagnostic workflows including infectious disease and environmental monitoring.

Released a revolutionary mutant Proteinase K with enhanced resistance and broader activity profiles—quickly adopted by researchers worldwide and featured in Science for its versatility.

Built a complete mRNA synthesis workflow including high-yield T7 RNA polymerase, clinical-grade NTPs, and CpG-enhancing elements, contributing to vaccine development and transcriptome studies.

Rolled out a comprehensive restriction enzyme platform, offering over 100 variants including GMP-certified options for manufacturing and clinical diagnostics.

Introduced RCA-focused enzymes such as phi29 HT polymerase, optimized for high-fidelity and long-read rolling circle amplification, especially in isothermal detection platforms.

Unveiled next-generation LAMP enzymes including heat-activated Bst P DNA polymerase, improving specificity, robustness, and speed in loop-mediated isothermal amplification assays.

SBS Genetech’s RPA platform to support multiplex amplification, enhancing simultaneous detection of multiple DNA targets in point-of-care and field-testing environments.

Delivered a complete CRISPR-based detection solution, featuring chemically synthesized sgRNAs and 20+ Cas protein variants, setting new standards for speed, accuracy, and portability.

Integrated six diagnostic technologies—PCR, LAMP, RPA, CRISPR, lateral flow strips, and freeze-drying—into a single platform for point-of-care testing (POCT), launching freeze-dried CRISPR-RPA test strip kits as the flagship product.